Effects of Mulligan Technique With or Without Diclofenac Phonophoresis on Patellofemoral Pain Syndrome.
Launched by UNIVERSITY OF LAHORE · May 31, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called the Mulligan technique, with or without a special ultrasound method using a pain-relieving gel, on patients with patellofemoral pain syndrome (PFPS). PFPS is a common cause of knee pain, especially in young women, and can make everyday activities like climbing stairs or sitting uncomfortable. The trial aims to determine how well these treatments relieve pain, improve movement, and help patients function better in their daily lives.
To participate in this study, individuals must be between 20 and 45 years old and experiencing pain in the front of one knee that has lasted for more than two months. They should also have a certain level of pain during activities and show positive results on specific physical tests. Participants will attend therapy sessions three times a week for four weeks, where they will receive standard physical therapy along with the experimental treatment if assigned to that group. The progress will be monitored by a trained assessor who does not know which treatment the participants are receiving. This study is currently recruiting participants, so if you or someone you know meets the criteria and is interested, it could be a great opportunity to find relief from knee pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patients of age range 20-45 years and both genders (Rehman, 2021 #171)
- • Unilateral anterior knee pain persisting for over two months, referred by orthopedic (Rehman, 2021 #171)
- • Pain scoring rate on numeric pain rating scale (NPRS) \>3 during at least two activities (Rehman, 2021 #171)
- • Patients with positive Clarke's test/ Patellar grind test (Rehman, 2021 #171)
- • Pain while going up and down stairs, when sitting with knees flexed and with squatting, kneeling or returning from squat. (Powers, 2017 #172)
- Exclusion Criteria:
- • • Patients with other knee pathologies; meniscus tears, bursitis, patellar tendon injury, ligamentous injury
- • Degenerative joint disorders; knee osteoarthritis, rheumatoid arthritis etc.
- • Patellofemoral dislocation and / or frequent subluxation.
- • Patients having undergone lower extremity surgery
- • Those taking any pain medications
About University Of Lahore
The University of Lahore is a leading academic institution dedicated to advancing healthcare research and education. With a robust commitment to scientific inquiry, the university sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Leveraging its state-of-the-art facilities and interdisciplinary expertise, the University of Lahore collaborates with healthcare professionals and researchers to conduct innovative studies that address pressing health challenges. Through its clinical trial initiatives, the university strives to contribute to evidence-based practices and foster advancements in clinical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Zunaira Saeed, Masters
Principal Investigator
University of Lahore
Umber Nawaz, PhD Scholar
Principal Investigator
University of Lahore
Ashfaq Ahmad, PhD
Study Chair
University of Lahore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported